After-Effects of the Cytostatic Therapy in Cardiology
Authors:
B. Mladosievičová
Authors‘ workplace:
Oddelenie klinickej patofyziológie Ústavu patologickej fyziológie LF UK, Bratis lava
Published in:
Čas. Lék. čes. 1999; : 138-141
Category:
Overview
As more and more oncologic patients are being cured from cancer, problems with long-term c ytostatic cardiologiccomplications have triggered and intensive investigation. Cardiotoxicity becomes a specific problem for those whosurvived cancer therapy with anthracycline. Heart failure or ventricular arrhythmias may develop from subclinicalmyocardial alterations induced by anthracycline therapy. Long-lasting monitoring of cardiac status may help toidentify those patients, whose abnormalities have progressive character and who are at risk of fatal complications
Key words:
cardiotoxicity, heart failure, ventricular arrhythmias, anthracycline..
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain managementArticle was published in
Journal of Czech Physicians
Most read in this issue
- Priapism
- Significance of Serum Cystatine C Levels Examination in PaediatricPatients with the Renal Impairment
- Warning Symptoms Preceding the Development of Septic Shock inNeutropenic Patients Treated on Acoount of Haematological Malignities
- Procollagen Type I and III in Patients with an Aneurysm of theAbdominal Aorta